Clincosm LogoSign in Get a demo

type 2 diabetes mellitus in obese

Showing 1 - 19 of 19
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)

Recruiting
  • Fibrosis, Liver
  • +2 more
  • La Jolla, California
    University of California, San Diego
Aug 25, 2023

Obesity, Type 2 Diabetes in Obese Trial in Newark (K-757 and K-833, Matching to K-757 and K-833)

Active, not recruiting
  • Obesity
  • Type 2 Diabetes Mellitus in Obese
  • K-757 and K-833
  • Matching placebo to K-757 and K-833
  • Newark, Delaware
    QPS, LLC
Jun 6, 2023

Type 2 Diabetes in Obese, Heart Failure With Preserved Ejection Fraction Trial in San Antonio (Pioglitazone, Placebo)

Not yet recruiting
  • Type 2 Diabetes Mellitus in Obese
  • Heart Failure With Preserved Ejection Fraction
  • San Antonio, Texas
    Texas Diabetes Institute/UH
Apr 20, 2023

Obesity, Obesity, Abdominal, Insulin Resistance Trial in Kyiv, Lviv (Postbiotic, Placebo)

Recruiting
  • Obesity
  • +5 more
  • Postbiotic
  • Placebo
  • Kyiv, Ukraine
  • +3 more
Mar 14, 2023

Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)

Completed
  • Type 2 Diabetes Mellitus in Obese
  • +2 more
  • Chula Vista, California
    ProSciento
Jan 26, 2023

Type 2 Diabetes in Obese Trial in Derby (Semaglutide Pen Injector [Ozempic], Very-low Calorie Diet)

Recruiting
  • Type 2 Diabetes Mellitus in Obese
  • Semaglutide Pen Injector [Ozempic]
  • Very-low Calorie Diet
  • Derby, United Kingdom
    University of Nottingham, Royal Derby Hospital Centre
Oct 31, 2022

Severe Obesity, Type 2 Diabetes in Obese Trial in São Paulo (Analyze basal expression incretin for immunolabeling and mRNA

Recruiting
  • Severe Obesity
  • Type 2 Diabetes Mellitus in Obese
  • Analyze basal expression incretin for immunolabeling and mRNA expression glucagon-like secretion peptide-1 (GLP-1) and peptide YY (PYY 3-36) incretins by L cells.
  • São Paulo, Brazil
    Hospital das Clinicas da Faculdade de Medicina da USP
Jul 7, 2022

Brain Health in Youth With Normal Weight, Overweight and Obesity

Recruiting
  • Type2 Diabetes
  • +10 more
  • Observational
  • Saint Louis, Missouri
  • +1 more
Jun 6, 2022

Type 2 Diabetes Mellitus With Obesity and Dyslipidemia Treated

Recruiting
  • Type 2 Diabetes Mellitus in Obese
  • Dyslipidemia Associated With Type II Diabetes Mellitus
  • Chinese herb medicine
  • Beijing, Beijing, China
    Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Apr 6, 2022

Obesity, Overweight, Overweight and Obesity Trial in Minneapolis (Physical Activity Intervention)

Recruiting
  • Obesity
  • +6 more
  • Physical Activity Intervention
  • Minneapolis, Minnesota
    University of Minnesota
Mar 9, 2022

CKD, Diabetic Kidney Disease, Type 2 Diabetes in Obese Trial in Danville, Wilkes-Barre (Semaglutide 2 mg/1.5 ml (1.34 mg/ml),

Recruiting
  • CKD
  • +4 more
  • Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution
  • Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution
  • Danville, Pennsylvania
  • +1 more
Feb 3, 2022

Type 2 Diabetes in Obese Trial (Low Carbohydrate diet)

Not yet recruiting
  • Type 2 Diabetes Mellitus in Obese
  • Low Carbohydrate diet
  • (no location specified)
Aug 4, 2021

Type 2 Diabetes, Diabetes, Type 2, Type 2 Diabetes in Obese Trial in Chicago (Aerobic exercise training)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Aerobic exercise training
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 8, 2021

Obesity, Uric Acid Stones, Type 2 Diabetes in Obese Trial in Gainesville (Phentermine / Topiramate Oral Product, Citrate Salts,

Recruiting
  • Obesity
  • +3 more
  • Phentermine / Topiramate Oral Product
  • Citrate Salts, Allopurinol, Diet
  • Gainesville, Florida
    University of Florida
Mar 31, 2021

The Effect of Exenatide on Fasting Bile Acids

Completed
  • Type 2 Diabetes Mellitus in Obese
  • Exenatide treatment
  • Beijing, China
    Beijing Chao-yang hospital
Jun 8, 2020

Type 2 Diabetes in Obese Trial in New Delhi (Low Calorie Diet)

Completed
  • Type 2 Diabetes Mellitus in Obese
  • Low Calorie Diet
  • New Delhi, Delhi, India
    Max Healthcare
Apr 24, 2020

CGMS in Diabetic Patients After Bariatric Surgery

Completed
  • Type 2 Diabetes Mellitus in Obese
  • Bariatric Surgery Candidate
  • routine care. No intervention
  • (no location specified)
Mar 31, 2020

Type 2 Diabetes in Obese Trial in Boston (NDPR diet, USDA healthy eating diet)

Withdrawn
  • Type 2 Diabetes Mellitus in Obese
  • NDPR diet
  • USDA healthy eating diet
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 13, 2020

Their Relationships With Glycemic and Weight Control in Hong

Completed
  • Type 2 Diabetes Mellitus in Obese
    • (no location specified)
    Jan 29, 2019